Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Ingresos totales | $8.3B | $8.3B | $8.3B | $8.2B | $8.1B | $8.2B | $7.3B |
| Beneficio bruto | $4.5B | $4.5B | $4.6B | $4.7B | $4.7B | $4.9B | $4.3B |
| % de margen bruto | 54.7% | 53.5% | 55.6% | 57.2% | 57.8% | 60.2% | 59.3% |
| Ingresos operativos (EBIT) | $2.1B | $2.2B | $1.0B | $1.7B | $1.7B | $1.9B | $1.4B |
| % de margen operativo | 25.0% | 26.2% | 12.6% | 20.6% | 20.8% | 23.0% | 19.6% |
| Ingresos netos | $1.4B | $1.6B | $479M | $1.3B | $1.3B | $1.5B | $1.1B |
| % de margen neto | 17.3% | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| EBITDA | — | $2.5B | $1.5B | $2.2B | $2.3B | $2.5B | $2.0B |
| Beneficio por acción (EPS) | $8.18 | $8.88 | $2.76 | $7.79 | $7.79 | $8.47 | $6.60 |
| Acciones en circulación (M) | — | 175M | 174M | 173M | 172M | 172M | 172M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de SOLV. /companies/us/SOLV
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms